In addition to its specific indications for Bipolar I Disorder, ABILIFY is indicated for the treatment of schizophrenia including maintaining stability in adults who had been symptomatically stable on other antipsychotic medications for periods of three months or longer and observed for relapse during a period of up to 26 weeks. Physicians who elect to use ABILIFY for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual.
| Website | http://abilify.com |
| Revenue | $1 million |
| Employees | 1 (1 on RocketReach) |
| Phone | +1 855-427-7470 |
| Industry | Manufacturing General, Health Care, Manufacturing, Medical |
| Competitors | Sam's Club, Concerta Consulting Inc, Vyvanse, Invega, Geodon, Zyprexa, Asri, Binpat, Benefix, Specialty Pharmaco (view competitors) |
| SIC | SIC Code 922 Companies, SIC Code 92 Companies |
| NAICS | NAICS Code 92212 Companies, NAICS Code 922 Companies, NAICS Code 92 Companies, NAICS Code 9221 Companies |
Looking for a particular abilify employee's phone or email?
The abilify annual revenue was $1 million in 2026.
1 people are employed at abilify.
abilify is based in Rockville, Maryland.
The NAICS codes for abilify are [92212, 922, 92, 9221].
The SIC codes for abilify are [922, 92].